RELX PLC (RELX) Fair Value & Analysis
Industrials · US · Market cap $54.9B
RELX PLC
RELX · US
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from $31.87 to $31.74 (−0.4%) since Jun 23, 2026. Share price −4.6% over the past month.
Price vs Fair Value (12 months)
12‑month range $27.13 – $52.88 · fair‑value band $19.75 – $40.62 · the $31.21 price screens below the $31.74 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
RELX PLC (RELX) currently trades at $31.21, while our model-based Fair Value estimate is $31.74 — implying the stock looks roughly 1.7% undervalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, RELX PLC generated revenue of $9.6B at a net margin of 21.5%. Revenue grew 1.2% year over year. It earns a return on equity of 70.5%. Net debt stands at $7.2B. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and change…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
RELX PLC reported revenue of $9.6B in FY2025 versus $7.2B in FY2021, a compound +7.3%/yr. Reported net income was $2.1B in FY2025, compounding +8.8%/yr from FY2021.
Open the full interactive analysis →
Recent news
- Is RELX PLC (RELX) A Good Stock To Buy Now?
- Goldman Sachs Initiates Coverage of RELX PLC (RELX) With a Buy
- Is AI a Source of Opportunity for RELX PLC (RELX)?
- Ubiquiti Upgraded, Reddit Downgraded: Updated Rankings on Top Blue-Chip Stocks
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
6 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Cintas Corporation CTAS | $169.45 | $82.75 | -51% |
| Thomson Reuters Corporation TRI | C$108.50 | C$70.40 | -35% |
| Copart, Inc CPRT | $30.77 | $28.89 | -6% |
| Global Payments Inc GPN | $65.09 | $70.80 | +9% |
| UL Solutions Inc ULS | $96.81 | $77.22 | -20% |
| RB Global, Inc RBA | $105.64 | $46.94 | -56% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is RELX PLC (RELX) undervalued?
What is the fair value of RELX?
What is the quality score of RELX?
What is the revenue of RELX PLC (RELX)?
What is the net profit margin of RELX?
Does RELX PLC pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.